Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Gene Editing Startup Beam Therapeutics Launches With $87M in Series A Funds

Gene Editing Startup Beam Therapeutics Launches With $87M in Series A Funds

May 17, 2018
|
staff reporter

NEW YORK (GenomeWeb) – Beam Therapeutics announced today that it has launched with $87 million in Series A funding to develop precision genetic medicines that make edits to individual base pairs in the genome.

The funding round was led by F-Prime Capital Partners and ARCH Venture Partners.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Even Bigger

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Got Into the Lab Machines

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Not Going to Pay

Science reports that a Dutch research funding agency is combating a ransomware attack.

Science Papers Present Haplotype-Resolved Genomes, MiRNA-Linked Complex Tied to Ribosomal Protein Production

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.

What's Popular?

In Business News

  1. Luminex Shares Surge on Rumor of Acquisition by DiaSorin

  2. 10x Genomics Acquires Denmark's Tetramer Shop

  3. Miroculus Raises $45M in Extended Series B Financing

  4. Guardant Health Q4 Revenues Up 25 Percent

  5. GenMark Diagnostics Q4 Revenues Rise 84 Percent on MDx Sales

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.